Gen-Plus finishes successfully the re-qualification of its PML-installation for any types of drug products based on film technology like Oral Dispersible Films and TTS-formulations. This gives us full reach now into the Clinical Trial Sample segment which means extended services and an organizational de-complexation for our clients. We are very happy about this achievement as it completes our Center of Excellence in the derma/topical segment.

Related Posts

  • From Houston to Munich – Innovation & Compounding

    read more

  • Gen-Plus donates € 10,000 to the Pro Retina Foundation

    read more

  • We wish all business partners a Merry Christmas and a healthy, happy 2023.

    read more